IDXX · 8-K · 20261102PR120892

Litigation and Legal Risk

IDEXX LABORATORIES INC /DE · 2026-11-02 · Importance 42 · Surprise 42

The release describes a concluded contract and patent-license royalty dispute concerning alleged underpayments for 2004–2017. After a 2025 appellate decision, IDEXX paid approximately $80 million on April 17, 2025, and the plaintiff filed a satisfaction and release of judgment the same day. The company also disclosed that it had reduced its related accrual by approximately $9 million in the first quarter of 2025; the matter is described as concluded.

Key facts

• IDEXX paid an approximately $80 million judgment on April 17, 2025, concluding a litigation matter over alleged underpayment of royalties for 2004–2017 under an expired patent license agreement. source
• IDEXX reduced its previously established $89.0 million accrual for a concluded litigation matter by approximately $9 million during Q1 2025. source
• IDEXX's projected 2026 comparable operating margin expansion reflects an approximately $9 million discrete litigation expense accrual adjustment in Q1 2025. source